| Literature DB >> 33899264 |
Giuseppe Lodi1, Mario Sannino1, Paolo Caterino1, Giovanni Cannarozzo1, Luigi Bennardo2, Steven Paul Nisticò2.
Abstract
Cutaneous leishmaniasis is challenging to treat. Various drugs have been proposed to manage this condition, with variable results. In this case report, we describe laser-assisted delivery of rifamycin to treat this infection. Two sessions of fractional CO2 laser were performed one month apart. Each was followed by a topical application of rifamycin for three days. Resolution with minimal scarring was obtained, suggesting this technique might be safe and effective in treating cutaneous leishmaniasis.Entities:
Keywords: cutaneous leishmaniasis; laser-assisted drug delivery; topical rifamycin
Year: 2021 PMID: 33899264 DOI: 10.1111/pde.14608
Source DB: PubMed Journal: Pediatr Dermatol ISSN: 0736-8046 Impact factor: 1.588